Intuitive Surgical’s second quarter results showcased impressive procedure growth and capital equipment placements, surpassing Wall Street’s projections. CEO Dave Rosa attributed the company’s success to the increasing adoption of the da Vinci 5 robotic surgical system in the U.S. and strategic expansion in key international markets. The revenue of $2.44 billion exceeded analyst estimates by 3.7%, reflecting a 21.
4% year-on-year growth. Adjusted EBITDA of $1.09 billion also outperformed expectations, with a 44.6% margin. During the earnings call, analysts posed insightful questions that delved into margin sustainability, innovation strategies, policy impacts on hospital spending, and productivity gains with the da Vinci 5 model. These inquiries provided valuable insights into Intuitive Surgical’s future direction and growth prospects.
Read more from finance.yahoo.com